510(k) K230253

OPTRELL™ Mapping Catheter with TRUEref™ Technology by Biosense Webster, Inc. — Product Code MTD

K230253 is an FDA 510(k) premarket notification submitted by Biosense Webster, Inc. for the device "OPTRELL™ Mapping Catheter with TRUEref™ Technology". The FDA issued a decision of Substantially Equivalent on Mar 2, 2023. The device falls under product code MTD (Catheter, Intracardiac Mapping, High-Density Array), a Class II device regulated under 21 CFR 870.1220. Biosense Webster, Inc. has 75 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 2, 2023
Date Received
Jan 31, 2023
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Catheter, Intracardiac Mapping, High-Density Array
Device Class
Class II
Regulation Number
870.1220
Review Panel
CV
Submission Type
510(k)

Need the full FDA record for Biosense Webster, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K230253. Report a data issue: hello@regdatalab.com.